Current RFPs
Clinical Trials in Immune Tolerance
The ITN is currently seeking Concept Proposals for novel clinical trials designed to induce immune tolerance in Type 1 Diabetes, transplantation, autoimmune diseases, and allergy and asthma. In addition, the ITN accepts applications for the development of novel tolerance assays or mechanistic studies for the purposes of establishing new surrogate biomarkers of immune tolerance and investigating the mechanisms of clinical tolerance.
Proposals should be submitted via our website: www.immunetolerance.org/submit-a-proposal
Detailed information and instructions: RFP - Clinical Trials in Immune Tolerance
Past RFPs
Request for Proposals - Combination Therapy Tolerance Trials in Allergy and Asthma
The ITN is currently seeking Concept Proposals for novel combination therapy clinical trials designed to induce immune tolerance in allergy and asthma. The ITN is especially interested in the following:
1) Studies with a tolerance endpoint that combine allergen-specific approaches with other immunomodulatory agents.
2) Development of novel tolerance assays to investigate allergen-specific mechanisms of clinical tolerance.
Deadline: August 17, 2012
Detailed information and instructions: RFP - Combination Therapy Trials and Allergy and Asthma
Request for Proposals – Clinical Trials of Allogeneic Solid Organ Transplantation Plus Therapeutic Cell Transfer
The ITN is currently seeking Concept Proposals for novel clinical trials designed to induce immune tolerance in combined allogeneic solid organ transplantation plus therapeutic cell transfer. The specific criteria and instructions for preparing proposals are in the following RFP.
Deadline: August 31, 2011
Detailed Information and Instructions: RFP – Allogeneic Solid Organ Transplantation Plus Therapeutic Cell Transfer
Request for Proposals - Clinical Trials in Rheumatologic Disease
The ITN is currently seeking Concept Proposals for novel clinical trials designed to induce immune tolerance in Rheumatologic Disorders and other areas of Autoimmune Disease.
Deadline: March 1, 2011
Detailed Information and Instructions: RFP - Clinical Trials in Rheumatologic Diseases
Request for Proposals - Clinical Trials in Psoriasis and Autoimmune Dermatological Disorders
The ITN is seeking ‘Proposal Outlines' for novel clinical trials designed to induce immune tolerance in psoriasis and other autoimmune skin disorders, including those mediated by autoantibodies such as pemphigus and pemphigoid.
DEADLINE: August 30, 2009
Detailed information and instructions: RFP - Psoriasis and Autoimmune Dermatological Disorders
Request for Expressions of Interest for Innovative Clinical Trials in Type 1 Diabetes
The purpose of this EOI is to gather information from the scientific community about novel ideas for tolerogenic immunotherapeutic trials in type 1 diabetes (T1D).
DEADLINE: April 13, 2009
Detailed information and instructions: EOI - Type 1 Diabetes
Research applications to the ITN are not limited to the RFAs seen here.The ITN accepts "Concept Proposals" year-round through it's always-open call for proposals. Visit the Proposals page for more information.